What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary areas of study are Internal medicine, Surgery, Procalcitonin, Respiratory disease and Randomized controlled trial.
Michael Tamm combines subjects such as Gastroenterology and Endocrinology with his study of Internal medicine.
His Surgery study combines topics in areas such as VO2 max, Anesthesia, Lung cancer and Pulmonary function testing.
His Procalcitonin research is multidisciplinary, relying on both Community-acquired pneumonia, Antibiotics, Intensive care, Intensive care medicine and Bronchitis.
The concepts of his Intensive care medicine study are interwoven with issues in Clinical endpoint and Respiratory tract infections.
His work carried out in the field of Respiratory disease brings together such families of science as Respiratory tract, Neutropenia, Aspergillosis and Carcinoma.
His most cited work include:
- Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial (873 citations)
- Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. (722 citations)
- Antibiotic Treatment of Exacerbations of COPD: A Randomized, Controlled Trial Comparing Procalcitonin-Guidance With Standard Therapy (434 citations)
What are the main themes of his work throughout his whole career to date?
Michael Tamm mainly focuses on Internal medicine, COPD, Immunology, Surgery and Lung.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Cardiology.
Michael Tamm combines subjects such as Hyaluronic acid, Pulmonary disease, Exacerbation, Intensive care medicine and Physical therapy with his study of COPD.
His Immunology study integrates concerns from other disciplines, such as Fibroblast, Cell growth and Transplantation.
His Lung research also works with subjects such as
- Pathology which is related to area like Respiratory disease,
- Cancer research that connect with fields like Mesenchymal stem cell.
His Procalcitonin research integrates issues from Antibiotics, Randomized controlled trial and Respiratory tract infections.
He most often published in these fields:
- Internal medicine (38.21%)
- COPD (23.09%)
- Immunology (17.94%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (38.21%)
- COPD (23.09%)
- Lung (13.62%)
In recent papers he was focusing on the following fields of study:
Michael Tamm mainly investigates Internal medicine, COPD, Lung, Gastroenterology and Exacerbation.
His Internal medicine course of study focuses on Endocrinology and Receptor.
His COPD research includes elements of Hyaluronic acid, Asthma, Immunology, Physical therapy and Cohort.
The study incorporates disciplines such as Cancer research and Mesenchymal stem cell, Pathology in addition to Lung.
His biological study spans a wide range of topics, including Procalcitonin and Antibiotics.
Michael Tamm interconnects Community-acquired pneumonia and Respiratory tract infections in the investigation of issues within Procalcitonin.
Between 2016 and 2021, his most popular works were:
- Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections (319 citations)
- Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis (182 citations)
- Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis (182 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
